The research result suggested that amidation-modified apelin-13 can also regulate the expression of PPARγ to inhibit the differentiation of adipocytes and regulate the expression of perilipin to promote lipolysis in vivo, and thereby improving obesity symptoms. The gene discussed is APLN; the disease is obesity due to melanocortin 4 receptor deficiency.